Conformis Income Statement 2022-2011 | CFMS

Brief overview of financial results at Conformis

The comparison covers a five-year financial horizon. According to figures from Conformis, revenue changed from 20.8 million dollars to 62 million dollars over five years. Across the full period, sales moved by +199%; the average annual rate was 24.5%. Revenue growth reflects a pronounced phase of business expansion.

At the gross-profit level, the result moved from $8.8 million to $23.2 million, a change of +165.1%. Cost of revenue developed more favorably than sales, supporting gross profitability. At the margin level, the figure shifted from 42.2% to 37.4%. The contraction points to pressure from direct costs or weaker pricing power.

EBITDA changed from −52.2 million dollars to −42.2 million dollars (+19%). EBITDA lagged revenue, showing weaker operating momentum. The EBITDA share of revenue changed from −251.4% to −68.1%. The increased EBITDA share is a positive sign.

Comparing the endpoints shows a move from −$11.9 million to −$50.5 million. Larger losses indicate rising pressure on the business.

Over the period, capitalization shifted from 58.9 million dollars to 12.6 million dollars (−78.6%). Investors remain cautious despite better financial results.

Overall conclusion

The financial trajectory is weak and requires a cautious interpretation. Key strengths include an improving EBITDA margin and a larger revenue base. The weaker side of the profile includes a weaker final result, declining capitalization and pressure from direct costs. The key question is whether sales can be converted into sustainable profit.